
Neoctide 0.1mg Injection
Marketer
Neon Laboratories Ltd
Salt Composition
Octreotide acetate (0.1mg)
Overview Neoctide 0.1mg Injection
Octreotide 0.1mg injection treats acromegaly, carcinoid tumors, and bleeding esophageal varices, and helps prevent post-pancreatic surgery complications. Administration is exclusively by a healthcare provider; self-injection is strictly prohibited. Dosage and frequency are determined solely by your physician. Consistent use is crucial for optimal therapeutic effect; discontinue only upon medical advisement. Common side effects include diarrhea, abdominal pain, nausea, constipation, gas, and headache. Report persistent or worsening side effects to your doctor. Prior to treatment, disclose any liver conditions and all other medications you are currently using.
Primary Ingredients of Neoctide 0.1mg Injection
No text provided to rephrase.
Uses of Neoctide 0.1mg Injection
Overgrowth of tissues (acromegaly)|Neuroendocrine cancers (carcinoid tumors)|Life-threatening esophageal bleeding
Major Benefits of Neoctide 0.1mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Neoctide 0.1mg Injection:
- Diarrhea
- Abdominal pain
- Nausea
- Constipation
- Flatulence
- Headache
- Increased glucose level in blood
- Injection site reaction
How to use Neoctide 0.1mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Neoctide 0.1mg Injection works:
Neoctide 0.1mg Injection mimics the action of somatostatin, an endogenous hormone that regulates the activity of various hormones, including growth hormone. Its mechanism of action also reduces gastrointestinal bleeding by vasoconstriction in the esophageal region.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Neoctide 0.1mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The administration of Neoctide 0.1mg Injection during gestation is typically deemed safe. Preclinical trials using animal models revealed minimal or absent harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Neoctide 0.1mg Injection while breastfeeding appears to pose minimal risk. Available human data indicates negligible harm to the infant.
DrivingSAFE
Driving ability is typically unaffected by Neoctide 0.1mg Injection.
KidneySAFE IF PRESCRIBED
Neoctide 0.1mg Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverCAUTION
Administering Neoctide 0.1mg Injection to patients with hepatic impairment requires careful consideration and potential dosage modification. Physician consultation is recommended.
What if you forget to take Neoctide 0.1mg Injection :
Should you forget a Neoctide 0.1mg Injection, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Neoctide 0.1mg Injection
| Label | Value |
|---|---|
| Chemical Type | Somatostatin analogs |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Actions | Somatostatin analogs |
